الملخص
Background: The surgical management of large-angle concomitant esotropia is challenging with high reoperation rates. This study aims to assess the effectiveness and safety of intraoperative botulinum toxin A (BTA) augmentation compared to surgery alone in large angle concomitant esotropia. Materials and methods: This is a prospective randomized interventional study. Patients with large angle concomitant esotropia (≥55 prism diopter [PD]) were randomly allocated to either surgery only (Group I) or BTA augmented surgery (Group II). The surgical effect in PD/mm was calculated and compared between the study groups at all follow up intervals. Treatment was considered successful if the patients had orthotropia ± 10 PD at their final examinations. Results: A total of 23 patients were included in the study, 11 in Group I and 12 in group II. The surgical effect was significantly greater in Group II compared to Group I at all follow up durations. The 1-year surgical effect was 32.5% greater in Group II compared to Group I (5.99 ± 0.69 vs. 4.52 ± 0.91 PD/mm, respectively, P = 0.001). The success rate was greater for Group II compared to Group I (75% vs. 63.64%, respectively), but this difference was not statistically significant (P = 0.901). Conclusion: Botulinum toxin augmented surgery is a good alternative to surgery alone in the treatment of large angle concomitant esotropia. BTA injection exerts a significant augmentation effect on medial rectus muscle recessions.
الكلمات المفتاحية
بيانات النشر
- المعرّف الرقمي
- 10.4103/ojo.ojo_106_23
- المجلة
- المجلة العُمانية لطب العيون, 17(1), 84-90
- الناشر
- منشورات ميدنو
- وصول مفتوح
- وصول مفتوح ذهبي
اقتبس هذه المقالة
APA 7
Alattar, S., Saad, M. S., Rashed, G. E. D., & Anwar, M. (2024). Botulinum toxin augmented surgery versus conventional surgery in the management of large-angle concomitant esotropia: A randomized clinical trial. Oman Journal of Ophthalmology, 17(1), 84-90. https://doi.org/10.4103/ojo.ojo_106_23
MLA 9
Alattar, Sara, et al. "Botulinum toxin augmented surgery versus conventional surgery in the management of large-angle concomitant esotropia: A randomized clinical trial." Oman Journal of Ophthalmology, vol. 17, no. 1, 2024, pp. 84-90. https://doi.org/10.4103/ojo.ojo_106_23.
شيكاغو (المؤلف–التاريخ)
Alattar, Sara, Mohamed Sayed Saad, Gamal El-Deen Rashed, and Mohamed Anwar. 2024. "Botulinum toxin augmented surgery versus conventional surgery in the management of large-angle concomitant esotropia: A randomized clinical trial." Oman Journal of Ophthalmology 17 (1): 84-90. https://doi.org/10.4103/ojo.ojo_106_23.
هارفارد
Alattar, S., Saad, M. S., Rashed, G. E. D. and Anwar, M. (2024) 'Botulinum toxin augmented surgery versus conventional surgery in the management of large-angle concomitant esotropia: A randomized clinical trial', Oman Journal of Ophthalmology, 17(1), pp. 84-90. doi:10.4103/ojo.ojo_106_23.
فانكوفر
Alattar S, Saad MS, Rashed GED, Anwar M. Botulinum toxin augmented surgery versus conventional surgery in the management of large-angle concomitant esotropia: A randomized clinical trial. Oman Journal of Ophthalmology. 2024;17(1):84-90. doi:10.4103/ojo.ojo_106_23
IEEE
S. Alattar, M. S. Saad, G. E. D. Rashed, and M. Anwar, "Botulinum toxin augmented surgery versus conventional surgery in the management of large-angle concomitant esotropia: A randomized clinical trial," Oman Journal of Ophthalmology, vol. 17, no. 1, pp. 84-90, 2024, doi: 10.4103/ojo.ojo_106_23.